Aquestive Therapeutics's market cap is currently $279.01M. The company's EPS TTM is $-0.449; its P/E ratio is ―; Aquestive Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 50.58M	$ 47.68M	$ 50.83M	$ 45.85M	$ 52.61M
Gross Profit	$ 29.75M	$ 28.29M	$ 35.84M	$ 32.88M	$ 32.25M
Operating Income	$ -15.10M	$ -42.07M	$ -34.68M	$ -42.89M	$ -52.67M
EBITDA	$ 1.18M	$ -39.58M	$ -45.11M	$ -39.15M	$ -53.88M
Net Income	$ -7.87M	$ -60.20M	$ -90.04M	$ -65.36M	$ -72.66M
Balance Sheet
Cash & Short-Term Investments	$ 23.87M	$ 27.27M	$ 28.02M	$ 31.81M	$ 49.33M
Total Assets	$ 57.42M	$ 55.67M	$ 61.99M	$ 62.88M	$ 78.48M
Total Debt	$ 33.32M	$ 56.09M	$ 56.42M	$ 40.48M	$ 60.34M
Net Debt	$ 9.45M	$ 28.82M	$ 28.40M	$ 8.67M	$ 11.01M
Total Liabilities	$ 163.91M	$ 174.23M	$ 144.13M	$ 111.38M	$ 84.60M
Stockholders' Equity	$ -106.49M	$ -118.55M	$ -82.13M	$ -48.50M	$ -6.12M
Cash Flow
Free Cash Flow	$ -7.38M	$ -12.31M	$ -33.89M	$ -45.98M	$ -60.87M
Operating Cash Flow	$ -6.38M	$ -9.79M	$ -32.98M	$ -45.46M	$ -60.21M
Investing Cash Flow	$ -995.00K	$ -2.52M	$ -913.00K	$ -517.00K	$ -663.00K
Financing Cash Flow	$ 3.97M	$ 11.56M	$ 30.11M	$ 28.46M	$ 49.60M

Currency in USD

Aquestive Therapeutics Earnings and Revenue History

Income Statement >

Aquestive Therapeutics Debt to Assets

Balance Sheet >

Aquestive Therapeutics Cash Flow

Cash Flow >

Aquestive Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing